120 filings
S-8
PASG
Passage Bio Inc
4 Mar 24
Registration of securities for employees
5:22pm
S-3
PASG
Passage Bio Inc
4 Mar 24
Shelf registration
4:09pm
10-K
2023 FY
PASG
Passage Bio Inc
Annual report
4 Mar 24
7:15am
8-K
PASG
Passage Bio Inc
4 Mar 24
Passage Bio Reports Fourth Quarter and Full-year 2023 Financial Results and Provides Recent Business Highlights
7:02am
8-K
PASG
Passage Bio Inc
29 Feb 24
Other Events
4:06pm
8-K
0m2t7 cx0v3lyq7e
5 Jan 24
Regulation FD Disclosure
4:05pm
8-K
xu6qjt j30t1sjbeam0
29 Dec 23
In the Court of Chancery of the State of Delaware
4:15pm
8-K
jwqpu3pd
20 Dec 23
Passage Bio Announces Promising Initial Data from Phase 1/2 Clinical Trial of PBFT02 In FTD-GRN and Updated Strategic Priorities
7:05am
8-K
1ipb2
13 Nov 23
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
7:00am
8-K
vkg dcvc2ar1wk0
1 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:10pm
8-K
dmpxxuzr4pe1f dldzm
7 Aug 23
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
7:15am
8-K
1v2xcnzz1ot mvi1o9fn
31 Jul 23
Departure of Directors or Certain Officers
7:00am
8-K
46v05blfrqf
20 Jul 23
Departure of Directors or Certain Officers
7:00am
8-K
7vguovf2w8oxch
26 May 23
Submission of Matters to a Vote of Security Holders
12:00am
8-K
800l66lzzc9aq14rhyzu
11 May 23
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
7:09am
ARS
u8mbcjear5r6 q9ef
14 Apr 23
Annual report to shareholders
7:37am
DEFA14A
rp1teu0
14 Apr 23
Additional proxy soliciting materials
7:34am